G protein-coupled receptor kinases (GRKs) are a family of serine/threonine kinases that phosphorylate agonist-bound, or activated, G protein-coupled receptors (GPCRs) as their primary substrates. On the basis of their sequence homology, GRKs can be subclassified into three groups: the visual subfamily (GRK1 and GRK7), the GRK4 subfamily (GRK4, GRK5 and GRK6) and the β-AR kinase (βARK) subfamily (GRK2 and GRK3). GRK1 and GRK7 are primarily expressed in retinal photoreceptor cells, whereas GRK4 is most abundantly expressed in the testes. GRK2, GRK3 and GRK5 are ubiquitously expressed, albeit to various extents in different tissues. In the heart, GRK2 and GRK5 are most prominent, whereas GRK3 and GRK6 are expressed at low levels. Functionally, all GRKs mediate the uncoupling and internalization of activated GPCRs. All GRKs are primarily localized to the cytosol and plasma membrane. GRK1, GRK4, GRK5, GRK6 and GRK7 are basally localized to the membrane. Conversely, GRK2 and GRK3 are primarily localized to the cytosol and translocate to the membrane after receptor stimulation.
CAY10594 是一种口服有效的 PLD2 抑制剂(IC50 为 140 nM),具有抗肿瘤、抗氧化和肝保护等活性,可用于乳腺癌、急性肝损伤和结肠炎等疾病的研究。
GRK2 modulator 1 是一种口服有效、可穿透血脑屏障且具有选择性的 GRK2 调节剂,可增强活性、非磷酸化的 GRK2 并防止线粒体 GRK2 和 TOMM6 聚集,增强 APP 的非淀粉样蛋白生成加工并防止 PHF-tau、神经退行性和神经元丢失,降低衰老标志物 UPAR、降低 AD 相关死亡率并延长生存期,通过抑制 HDAC6 发挥神经保护作用并对抗与年龄相关的心脏功能障碍,可用于阿尔茨海默病的研究。
Obuprazine 是一种口服活性的多巴胺 D3 受体 (dopamine D3 receptor) 激动剂和 5-HT2A 受体拮抗剂,其 IC50 值分别为 0.37 nM 和 4.19 nM,可作为 G 蛋白偶联受体 (G protein-coupled receptor) 调节剂,用于精神分裂症的研究。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号